Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
International Journal of Pharmaceutics|September 2, 2015
Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effectsSohee Son, Sung Mook Lim, Su Young Chae, et al.The Breast Journal|June 13, 2019
Effect of primary tumor resection on overall survival in patients with stage IV breast cancerSung Mook Lim, Jee Ye Kim, Hyung Seok Park, et al.Breast Cancer Research and Treatment|August 22, 2016
Resting heart rate as a prognostic factor for mortality in patients with breast cancerDong Hoon Lee, Seho Park, Sung Mook Lim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2012
PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targetingTae Hyung Kim, Young Gi Jo, Hai Hua Jiang, et al.Bioconjugate Chemistry|November 3, 2012
Site-specific PEGylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effectsTae Hyung Kim, Hai Hua Jiang, Sung Mook Lim, et al.Gland Surgery|August 11, 2020
Conserving the lymphatics from the arm using fluorescence imaging in patients with breast cancer at high risk of postoperative lymphedema: a pilot studyKwang Hyun Yoon, Sung Mook Lim, Bonyong Koo, et al.Journal of Pharmaceutical Sciences|July 30, 2010
Preparation and characterization of Apo2L/TNF-related apoptosis-inducing ligand-loaded human serum albumin nanoparticles with improved stability and tumor distributionTae Hyung Kim, Hai-Hua Jiang, Yu Seok Youn, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2017
PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cellsJong-Sung Park, Yumin Oh, Ogyi Park, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2015
Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumorsYumin Oh, Magdalena Swierczewska, Tae Hyung Kim, et al.World Journal of Surgery|July 1, 2018
Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cmHyeon Woo Bae, Kwang Hyun Yoon, Joo Heung Kim, et al.Pageof 3